SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.
Conditions
Painful Peripheral Neuropathy · Diabetic Peripheral Neuropathic Pain (DPN) · Chemotherapy Induced Peripheral Neuropathy (CIPN) · Idiopathic Peripheral Neuropathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beth Israel Deaconess Medical Center for Autonomic and Peripheral Nerve Disorders, Boston, Massachusetts, United States
Contact: Principal Investigator (Roy Freeman, MD)Ichan School of Medicine at Mount Sinai, New York, New York, United States
Contact: Principal Investigator (Jessica Robinson-Papp, MD)University of Rochester, Rochester, New York, United States
Contact: Principal Investigator (Jennifer Gewandter, PhD, MPH)University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Ajay Wasan, MD)University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Rob Singleton, MD)University of Vermont, Burlington, Vermont, United States
Contact: Principal Investigator (Noah Kolb, MD)VCU Medical Center, Richmond, Virginia, United States
Contact: Principal Investigator (Gordon Smith, MD)
Study leads
Jennifer Gewandter, PhD, MPH
Principal Investigator
University of Rochester